Citation Impact
Citing Papers
Change of Serum Antithyroglobulin Antibody Levels Is Useful for Prediction of Clinical Recurrence in Thyroglobulin-Negative Patients with Differentiated Thyroid Carcinoma
2008
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement
2013
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
2007
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
Italian consensus for the classification and reporting of thyroid cytology
2014 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview
2012
Health‐related quality of life among thyroid cancer survivors: a systematic review
2011
Thyroid cancer
2016 Standout
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
2013
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study
2001
High prevalence of differentiated thyroid carcinoma in acromegaly
2005
Identification of occult metastases of medullary thyroid carcinoma by pentagastrin‐stimulated intravenous calcitonin sampling followed by targeted surgery
2007
Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer
2011
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
2008 Standout
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
2004
Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
2011
Risk of Thyroid Nodular Disease and Thyroid Cancer in Patients with Acromegaly – Meta-Analysis and Systematic Review
2014
Acromegaly: Re-thinking the cancer risk
2007
Preoperative evaluation of thyroid nodules with 18FDG-PET/CT
2005
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
Phaeochromocytoma
2005 Standout
Head and neck cancer
2008 Standout
Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET
2005
American Thyroid Association Statement on Preoperative Imaging for Thyroid Cancer Surgery
2014
Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
2008
Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study
2006
Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer
2011
Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care
2013
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma
2007
Radioactive iodine in the treatment of medullary thyroid carcinoma: a controlled multicenter study
2013
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
2009
The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
2012 Standout
Utilidad de la 18F-FDG PET/TC en el cáncer de tiroides
2016
Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice
2004
Recurrent Differentiated Thyroid Cancer
2012
Normal Range of Calcitonin in Children Measured by a Chemiluminescent Two-Site Immunometric Assay
2006
The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center
2011
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Das medulläre Schilddrüsenkarzinom
2015
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS
2017 Standout
Graves' Ophthalmopathy
2010 Standout
Positron emission tomography and positron emission tomography‐CT evaluation for recurrent papillary thyroid carcinoma: Meta‐analysis and literature review
2010
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
2003
Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients
2013
Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking
2007
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Dosimetry and thyroid cancer: the individual dosage of radioiodine
2010
Associations between benefit finding and adjustment outcomes in thyroid cancer
2011
Persistent Posttreatment Fatigue in Thyroid Cancer Survivors
2014
Thyroglobulin antibody (TgAb) methods – Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer
2013
The Role of Positron Emission Tomography/Computed Tomography in the Management of Recurrent Papillary Thyroid Carcinoma
2005
Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer
2008
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma
2001
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee
2017 Standout
Detection of Metastatic Cervical Lymph Nodes in Recurrent Papillary Thyroid Carcinoma
2009
Thyroid cancer in childhood: Management strategy, including dosimetry and long-term results
2007
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
2009
Psychological Well-Being Revisited: Advances in the Science and Practice of Eudaimonia
2013 Standout
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes
2015
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using 18F‐FDG PET/CT
2009
Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors
2012
Current Thyroglobulin Autoantibody (TgAb) Assays Often Fail to Detect Interfering TgAb that Can Result in the Reporting of Falsely Low/Undetectable Serum Tg IMA Values for Patients with Differentiated Thyroid Cancer
2011
Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients
2009
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer
2003
Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels
2007
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Advances in the follow-up of differentiated or medullary thyroid cancer
2012
Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer
2004
Psychological impact of thyroid surgery on patients with well-differentiated papillary thyroid cancer
2011
Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC)
2011
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
2012
Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly
2004
Positron emission imaging of head and neck cancer, including thyroid carcinoma
2004
Benign and Malignant Thyroid Nodules: US Differentiation—Multicenter Retrospective Study
2008 Standout
Relative Quantification of Indium-111 Pentetreotide and Gallium-68 DOTATOC Uptake in the Thyroid Gland and Association with Thyroid Pathologies
2009
Lack of Elevated Serum Carcinoembryonic Antigen and Calcitonin in Medullary Thyroid Carcinoma
2004
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
The 2017 Bethesda System for Reporting Thyroid Cytopathology
2017 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Sequential Changes of Serum Antithyroglobulin Antibody Levels Are a Good Predictor of Disease Activity in Thyroglobulin-Negative Patients with Papillary Thyroid Carcinoma
2013
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma
2005
124 I Positron Emission Tomography Versus 131 I Planar Imaging in the Identification of Residual Thyroid Tissue and/or Metastasis in Patients Who Have Well-Differentiated Thyroid Cancer
2010
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Patient Age Is Significantly Related to the Progression of Papillary Microcarcinoma of the Thyroid Under Observation
2013 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Advances in Ultrasound for the Diagnosis and Management of Thyroid Cancer
2009
Quality of Life in Patients with Thyroid Cancer Compared with the General Population
2011
A Systematic Review of Randomized Controlled Trials for Management of Persistent Post-Treatment Fatigue in Thyroid Cancer Survivors
2014
Role of Neck Ultrasonography in the Follow-Up of Children Operated on for Thyroid Papillary Cancer
2003
Frequency and Relevance of Elevated Calcitonin Levels in Patients with Neoplastic and Nonneoplastic Thyroid Disease and in Healthy Subjects
2004
Management of Graves’ Ophthalmopathy: Reality and Perspectives*
2000
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Nuklearmedizinische Therapie und Nachsorge des differenzierten Schilddrüsenkarzinoms: Status quo
2010
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Clinical Relevance of Single-Photon Emission Computed Tomography/Computed Tomography of the Neck and Thorax in Postablation 131I Scintigraphy for Thyroid Cancer
2009
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy
2007
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
2013 Standout
Prognostic significance of changes in serum thyroglobulin antibody levels of pre- and post-total thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients
2013
Medullary thyroid cancer diagnosis: An appraisal
2013
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
MRI Versus 131I Whole-Body Scintigraphy for the Detection of Lymph Node Recurrences in Differentiated Thyroid Carcinoma
2010
Assessment of the Incremental Value of Recombinant Thyrotropin Stimulation before 2-[18F]-Fluoro-2-Deoxy-d -Glucose Positron Emission Tomography/Computed Tomography Imaging to Localize Residual Differentiated Thyroid Cancer
2009
Quality of Life and Anxiety in Adolescents with Differentiated Thyroid Cancer
2012
Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
2012
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
2004
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
2012
Cancer treatment and survivorship statistics, 2019
2019 Standout
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.
2002
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Guidelines for the management of thyroid cancer
2014 Standout
Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial
2007
New Paradigms in the Diagnosis and Management of Thyroid Nodules
2007
Thyroid carcinoma
2003 Standout
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
2012
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
2016 Standout
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I
2009
Diagnosis of Thyroid Follicular Carcinoma by the Vascular Pattern and Velocimetric Parameters Using High Resolution Pulsed and Power Doppler Ultrasonography
2005
Works of Rainer Görges being referenced
18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy
2012
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET
2008
Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
2000
Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment
2005
Diagnosis in Medullary Thyroid Cancer with [18F]FDG‐PET and Improvement Using a Combined PET/CT Scanner
2003
Preoperative Diagnostic Value of [18F] Fluorodeoxyglucose Positron Emission Tomography in Patients With Radioiodine-Negative Recurrent Well-Differentiated Thyroid Carcinoma
2001
Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study
2002
Protektive Faktoren für Angst und Depression bei Schilddrüsenkarzinompatienten
2007
Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancer
2003
Radionuclide-Labeled Somatostatin Analogues for Diagnostic and Therapeutic Purposes in Nonmedullary Thyroid Cancer
2001
Impact of Disease Activity on Thyroid Diseases in Patients with Acromegaly: Basal Evaluation and Follow-up
2004
Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report
2003
The value of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with medullary thyroid cancer
2000
Health-related Quality of Life, Depression and Anxiety in Thyroid Cancer Patients
2006
Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease.
2002
Basal and Stimulated Calcitonin and Procalcitonin by Various Assays in Patients with and without Medullary Thyroid Cancer
2010
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy
2005
Improved Diagnostic Methods in the Follow-Up of Medullary Thyroid Carcinoma by Highly Specific Calcitonin Measurements*
2000
124I-PET/CT in metastatic follicular thyroid carcinoma
2002
Indium-111-pentetreotide in Graves' disease.
1998
124I-PET dosimetry in advanced differentiated thyroid cancer: Therapeutic impact
2007